Roy BaynesMBBCh, MMed, FCP, MD, PhD
Roy Baynes, MD, PhD, is Senior Vice President Global Clinical Development at Merck Research Laboratories in Rahway, New Jersey. He was previously Senior Vice President of Oncology, Inflammation and Respiratory Therapeutics at Gilead Sciences and prior to that was Vice President Global Clinical Development, and Therapeutic Area (TA) Head for Hematology / Oncology, at Amgen Inc.
Dr Baynes graduated as a Medical Doctor and obtained a Master of Medicine and Doctor of Philosophy from the University of the Witwatersrand, Johannesburg, South Africa. He has had a long and distinguished career in the hematology-oncology-and stem cell transplantation fields, including drug development, basic research, clinical practice, clinical research, teaching and administration.
He is a member of many international societies, including the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR) and has authored some 150 publications. Before joining Industry in 2002, Dr Baynes was the Charles Martin Professor of Cancer Research at the Barbara Ann Karmanos Cancer Institute, an NCI designated Comprehensive Cancer Center, at Wayne State University, Detroit, Michigan, USA.